Published: Mar 23, 2020, 24:25 IST | Updated: Mar 23, 2020, 24:25 IST
Icmr approves use of anti-malarial drug in high risk. ICMR holds a press briefing today and clarify that this drug is only use by those health workers who are treating Covid 19 patients.